NVOLawsuitsprnewswire

NVO Investors Have Opportunity to Lead Novo Nordisk A/S Securities Fraud Lawsuit with the Schall Law Firm

Sentiment:Negative (-60)

Summary

LOS ANGELES, Aug. 12, 2025 /PRNewswire/ -- The Schall Law Firm, a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Novo Nordisk A/S ("Novo Nordisk" or "the Company") (NYSE: NVO) for violations of §§10(b) and 20(a) of the Securities Exchange...

Original Article

Read the full article from the original source for complete details and context.

Read Full Article

Article published on August 12, 2025 by prnewswire